Artemis Medicare Services Complete Financial Statements
In FY2026, Artemis Medicare Services (ARTEMISMED) reported revenue ₹287 Cr, net profit ₹30 Cr and EPS ₹1.90, with a net profit margin of 10.5% and ROE of 3.2%. Full financial statements from FY2018 to FY2026 (9 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore Artemis Medicare Services intrinsic worth to estimate fundamental worth using multiple valuation models.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
ARTEMISMED Revenue, Net Profit & EBITDA — Year-on-Year Growth
ARTEMISMED YoY (Mar 2025 vs Mar 2026) — revenue +13.9%, net profit +30.4%, EBITDA +22.9%, expenses +11.8%. Review Artemis Medicare Services P/E valuation to evaluate earnings-based valuation against sector peers.
ARTEMISMED Income Statement — Revenue, EBITDA & Net Profit
Artemis Medicare Services revenue ₹287 Cr, EBITDA ₹59 Cr, net profit ₹30 Cr, EPS ₹1.90 (2026) — net profit margin 10.5%. For live price, earnings ratios and company overview, see ARTEMISMED share price screener.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 287 | 282 | 252 | 262 | 280 | 249 | 227 | 228 | 241 | 227 | 198 | 211 | 221 | 189 | 151 | 170 | 189 | 140 | 134 | 123 | 145 | 93 | 141 | 63 | 125 | 149 | 142 | 136 | 144 | 140 |
| Expenses | 228 | 224 | 204 | 214 | 231 | 199 | 187 | 187 | 195 | 191 | 170 | 182 | 186 | 164 | 132 | 148 | 162 | 119 | 109 | 109 | 126 | 85 | 126 | 72 | 108 | 130 | 122 | 121 | 127 | 122 |
| EBITDA | 59 | 58 | 48 | 48 | 49 | 50 | 40 | 41 | 46 | 37 | 28 | 29 | 34 | 25 | 18 | 22 | 27 | 21 | 25 | 14 | 19 | 9 | 15 | -8 | 17 | 18 | 19 | 15 | 17 | 18 |
| Operating Profit Margin % | 18.00% | 18.00% | 15.00% | 16.00% | 15.00% | 18.00% | 17.00% | 16.00% | 16.00% | 15.00% | 13.00% | 13.00% | 15.00% | 13.00% | 11.00% | 11.00% | 14.00% | 14.00% | 16.00% | 11.00% | 12.00% | 9.00% | 9.00% | -14.00% | 13.00% | 12.00% | 13.00% | 11.00% | 12.00% | 12.00% |
| Depreciation | 13 | 12 | 12 | 11 | 12 | 11 | 11 | 11 | 11 | 10 | 9 | 9 | 10 | 7 | 6 | 7 | 8 | 5 | 5 | 5 | 6 | 5 | 6 | 6 | 5 | 6 | 5 | 5 | 6 | 5 |
| Interest | 6 | 7 | 8 | 7 | 7 | 8 | 9 | 8 | 8 | 8 | 5 | 7 | 8 | 5 | 4 | 4 | 5 | 3 | 3 | 2 | 3 | 4 | 3 | 4 | 3 | 4 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 40 | 39 | 29 | 30 | 30 | 31 | 20 | 22 | 27 | 19 | 14 | 13 | 16 | 13 | 8 | 11 | 13 | 13 | 17 | 6 | 10 | 0 | 6 | -18 | 8 | 9 | 11 | 7 | 9 | 10 |
| Tax | 10 | 9 | 6 | 9 | 8 | 8 | 6 | 5 | 6 | 5 | 3 | 3 | 5 | 4 | -5 | 2 | 3 | 5 | 5 | 3 | 4 | 0 | 2 | -6 | 3 | 4 | 6 | 2 | 3 | 5 |
| Net Profit | 30 | 30 | 23 | 21 | 22 | 22 | 14 | 17 | 21 | 14 | 11 | 10 | 12 | 9 | 13 | 8 | 10 | 8 | 13 | 4 | 6 | 0 | 4 | -12 | 5 | 5 | 6 | 4 | 6 | 5 |
| Earnings Per Share (₹) | 1.90 | 1.90 | 1.47 | 1.35 | 1.41 | 1.42 | 1.04 | 1.14 | 1.32 | 1.00 | 0.79 | 0.72 | 0.85 | 0.68 | 1.00 | 0.64 | 0.78 | 0.62 | 9.59 | 2.93 | 0.49 | 0.11 | 3.26 | -8.83 | 4.03 | 4.18 | 4.21 | 3.26 | 4.25 | 3.71 |
ARTEMISMED Balance Sheet — Assets, Liabilities & Shareholders' Equity
ARTEMISMED total assets ₹1,429 Cr, total equity ₹935 Cr, total liabilities ₹ Cr (2026) — ROE 3.2%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Total Assets | 1,429 | 1,357 | 972 | 905 | 710 | 600 | 586 | 554 |
| Current Assets | 367 | 539 | 180 | 170 | 127 | 110 | 118 | 113 |
| Fixed Assets | 791 | 745 | 719 | 605 | 489 | 383 | 393 | 381 |
| Capital Work in Progress | 28 | 40 | 33 | 95 | 64 | 81 | 56 | 49 |
| Investments | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 572 | 219 | 205 | 157 | 136 | 138 | 124 |
| LIABILITIES | ||||||||
| Total Liabilities | ||||||||
| Current Liabilities | 277 | 298 | 332 | 292 | 210 | 160 | 115 | 84 |
| Non-Current Liabilities | ||||||||
| SHAREHOLDERS' EQUITY | ||||||||
| Total Equity | 935 | 844 | 455 | 408 | 361 | 322 | 314 | 293 |
| Share Capital | 16 | 14 | 14 | 13 | 13 | 13 | 13 | 13 |
| Reserves & Surplus | 919 | 824 | 435 | 390 | 346 | 307 | 300 | 280 |
ARTEMISMED Cash Flow Statement — Operating, Investing & Financing
Artemis Medicare Services operating cash flow ₹146 Cr, investing ₹-385 Cr, financing ₹267 Cr, net cash flow ₹27 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | 146 | 109 | 127 | 60 | 27 | 56 | 41 |
| Investing Activities | -385 | -88 | -158 | -107 | -37 | -26 | -50 |
| Financing Activities | 267 | -29 | 38 | 44 | 18 | -27 | 14 |
| Net Cash Flow | 27 | -8 | 7 | -4 | 8 | 2 | 5 |